ネクセラファーマの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/05/17 | 1,514 | 1,514 | 1,468 | 1,468 | -52 | -3.4% | 1,096,400 |
2024/05/16 | 1,515 | 1,537 | 1,514 | 1,520 | +19 | +1.3% | 540,000 |
2024/05/15 | 1,567 | 1,594 | 1,501 | 1,501 | -61 | -3.9% | 959,700 |
2024/05/14 | 1,520 | 1,570 | 1,513 | 1,562 | +52 | +3.4% | 727,800 |
2024/05/13 | 1,490 | 1,532 | 1,485 | 1,510 | +14 | +0.9% | 652,700 |
2024/05/10 | 1,489 | 1,579 | 1,475 | 1,496 | -55 | -3.5% | 1,397,400 |
2024/05/09 | 1,540 | 1,565 | 1,528 | 1,551 | +5 | +0.3% | 663,000 |
2024/05/08 | 1,520 | 1,567 | 1,510 | 1,546 | +22 | +1.4% | 795,700 |
2024/05/07 | 1,516 | 1,540 | 1,496 | 1,524 | +5 | +0.3% | 913,100 |
2024/05/02 | 1,497 | 1,528 | 1,476 | 1,519 | +25 | +1.7% | 644,100 |
2024/05/01 | 1,466 | 1,526 | 1,458 | 1,494 | +26 | +1.8% | 831,100 |
2024/04/30 | 1,485 | 1,487 | 1,452 | 1,468 | +10 | +0.7% | 772,100 |
2024/04/26 | 1,503 | 1,505 | 1,453 | 1,458 | -37 | -2.5% | 3,093,200 |
2024/04/25 | 1,496 | 1,534 | 1,493 | 1,495 | -13 | -0.9% | 731,300 |
2024/04/24 | 1,488 | 1,519 | 1,481 | 1,508 | +28 | +1.9% | 708,600 |
2024/04/23 | 1,477 | 1,489 | 1,463 | 1,480 | +13 | +0.9% | 584,900 |
2024/04/22 | 1,466 | 1,482 | 1,457 | 1,467 | +17 | +1.2% | 602,200 |
2024/04/19 | 1,499 | 1,505 | 1,448 | 1,450 | -61 | -4% | 1,064,700 |
2024/04/18 | 1,480 | 1,529 | 1,474 | 1,511 | +48 | +3.3% | 762,900 |
2024/04/17 | 1,516 | 1,552 | 1,463 | 1,463 | +7 | +0.5% | 1,376,800 |
2024/04/16 | 1,485 | 1,492 | 1,451 | 1,456 | -57 | -3.8% | 891,700 |
2024/04/15 | 1,488 | 1,529 | 1,470 | 1,513 | +13 | +0.9% | 950,200 |
2024/04/12 | 1,530 | 1,537 | 1,463 | 1,500 | -60 | -3.8% | 1,773,000 |
2024/04/11 | 1,571 | 1,595 | 1,554 | 1,560 | -31 | -1.9% | 899,800 |
2024/04/10 | 1,608 | 1,620 | 1,571 | 1,591 | -31 | -1.9% | 772,800 |
2024/04/09 | 1,627 | 1,642 | 1,599 | 1,622 | +73 | +4.7% | 1,736,500 |
2024/04/08 | 1,544 | 1,567 | 1,531 | 1,549 | +15 | +1% | 759,100 |
2024/04/05 | 1,530 | 1,541 | 1,483 | 1,534 | -36 | -2.3% | 1,245,800 |
2024/04/04 | 1,550 | 1,583 | 1,538 | 1,570 | +26 | +1.7% | 720,300 |
2024/04/03 | 1,543 | 1,558 | 1,503 | 1,544 | -13 | -0.8% | 1,046,700 |
2024/04/02 | 1,614 | 1,616 | 1,547 | 1,557 | -81 | -4.9% | 1,057,000 |
2024/04/01 | 1,660 | 1,667 | 1,610 | 1,638 | -24 | -1.4% | 824,600 |
2024/03/29 | 1,626 | 1,670 | 1,626 | 1,662 | +41 | +2.5% | 950,200 |
2024/03/28 | 1,627 | 1,652 | 1,603 | 1,621 | +19 | +1.2% | 990,700 |
2024/03/27 | 1,618 | 1,627 | 1,578 | 1,602 | -12 | -0.7% | 1,054,800 |
2024/03/26 | 1,574 | 1,637 | 1,563 | 1,614 | +36 | +2.3% | 1,128,900 |
2024/03/25 | 1,589 | 1,622 | 1,577 | 1,578 | -12 | -0.8% | 736,100 |
2024/03/22 | 1,596 | 1,604 | 1,559 | 1,590 | -4 | -0.3% | 753,600 |
2024/03/21 | 1,579 | 1,596 | 1,565 | 1,594 | +53 | +3.4% | 1,286,100 |
2024/03/19 | 1,567 | 1,570 | 1,532 | 1,541 | -18 | -1.2% | 608,100 |
2024/03/18 | 1,518 | 1,564 | 1,515 | 1,559 | +50 | +3.3% | 1,096,300 |
2024/03/15 | 1,525 | 1,537 | 1,483 | 1,509 | -51 | -3.3% | 1,550,700 |
2024/03/14 | 1,550 | 1,586 | 1,530 | 1,560 | +3 | +0.2% | 980,200 |
2024/03/13 | 1,592 | 1,592 | 1,529 | 1,557 | -25 | -1.6% | 1,615,500 |
2024/03/12 | 1,615 | 1,649 | 1,560 | 1,582 | -153 | -8.8% | 5,022,800 |
2024/03/11 | 1,770 | 1,780 | 1,707 | 1,735 | -53 | -3% | 1,905,400 |
2024/03/08 | 1,671 | 1,826 | 1,664 | 1,788 | +126 | +7.6% | 4,810,300 |
2024/03/07 | 1,606 | 1,662 | 1,570 | 1,662 | +65 | +4.1% | 2,001,600 |
2024/03/06 | 1,500 | 1,599 | 1,497 | 1,597 | +82 | +5.4% | 2,009,700 |
2024/03/05 | 1,469 | 1,546 | 1,457 | 1,515 | +29 | +2% | 1,103,400 |
1~
50
件表示中 / 4847件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ネクセラファーマ | 146,800円 | +150.7% | - | 0.00% | 37.71倍 | 1.98倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
東和薬品 | 274,000円 | +14.7% | -28.1% | 2.19% | 11.63倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
住友ファーマ | 33,600円 | +7.5% | - | 0.00% | - | 0.86倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
持田薬 | 305,500円 | +3.0% | +27.5% | 2.62% | 19.34倍 | 0.85倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
鳥居薬 | 389,500円 | +7.3% | +16.8% | 3.08% | 23.30倍 | 0.91倍 |
|
JT傘下。自社製品の腎・透析、アレルゲン等の開発強化。柱の抗HIV薬の販売権喪失が直撃 |
市場注目の銘柄
チャート関連のコラム